246 related articles for article (PubMed ID: 30827274)
1. Clostridium Difficile Infection in Inflammatory Bowel Disease Patients.
Albarrak AA; Romana BS; Uraz S; Yousef MH; Juboori AA; Tahan V
Endocr Metab Immune Disord Drug Targets; 2019; 19(7):929-935. PubMed ID: 30827274
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile infection and inflammatory bowel disease: what gastroenterologists and surgeons should know.
Cojocariu C; Trifan A; Stoica O; Chihaia CA; Stanciu C
Chirurgia (Bucur); 2014; 109(5):579-83. PubMed ID: 25532244
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
Nitzan O; Elias M; Chazan B; Raz R; Saliba W
World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
[TBL] [Abstract][Full Text] [Related]
4. Clostridium difficile in inflammatory bowel disease.
Alhobayb T; Ciorba MA
Curr Opin Gastroenterol; 2023 Jul; 39(4):257-262. PubMed ID: 37265220
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
[TBL] [Abstract][Full Text] [Related]
6. Management of inflammatory bowel disease with
D'Aoust J; Battat R; Bessissow T
World J Gastroenterol; 2017 Jul; 23(27):4986-5003. PubMed ID: 28785153
[TBL] [Abstract][Full Text] [Related]
7. Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
Rao K; Safdar N
J Hosp Med; 2016 Jan; 11(1):56-61. PubMed ID: 26344412
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease.
Gholam-Mostafaei FS; Yadegar A; Aghdaei HA; Azimirad M; Daryani NE; Zali MR
Curr Res Transl Med; 2020 Aug; 68(3):125-130. PubMed ID: 32414632
[TBL] [Abstract][Full Text] [Related]
9. Clostridioides difficile infection in inflammatory bowel disease: a clinical review.
Tang M; Wang C; Xia Y; Tang J; Wang J; Shen L
Expert Rev Anti Infect Ther; 2024 May; 22(5):297-306. PubMed ID: 38676422
[TBL] [Abstract][Full Text] [Related]
10. Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.
Hourigan SK; Chen LA; Grigoryan Z; Laroche G; Weidner M; Sears CL; Oliva-Hemker M
Aliment Pharmacol Ther; 2015 Sep; 42(6):741-52. PubMed ID: 26198180
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile infection and inflammatory bowel disease.
Cojocariu C; Stanciu C; Stoica O; Singeap AM; Sfarti C; Girleanu I; Trifan A
Turk J Gastroenterol; 2014 Dec; 25(6):603-10. PubMed ID: 25599768
[TBL] [Abstract][Full Text] [Related]
12. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection.
De Leon LM; Watson JB; Kelly CR
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1036-8. PubMed ID: 23669309
[TBL] [Abstract][Full Text] [Related]
13. Clostridioides difficile Infection in Pediatric Inflammatory Bowel Disease.
Reasoner SA; Nicholson MR
Curr Gastroenterol Rep; 2023 Nov; 25(11):316-322. PubMed ID: 37646895
[TBL] [Abstract][Full Text] [Related]
14. [Advances in the diagnosis and treatment of Clostridioides [Clostridium] difficile infections in inflammatory bowel disease].
Stallmach A; Reuken PA; Teich N
Z Gastroenterol; 2018 Nov; 56(11):1369-1377. PubMed ID: 30419580
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease.
Dalal RS; Allegretti JR
Curr Opin Gastroenterol; 2021 Jul; 37(4):336-343. PubMed ID: 33654015
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with inflammatory bowel disease.
You JHS; Jiang X; Lee WH; Chan PKS; Ng SC
J Gastroenterol Hepatol; 2020 Sep; 35(9):1515-1523. PubMed ID: 32017248
[TBL] [Abstract][Full Text] [Related]
17. [
Lee MR; Kim ES
Korean J Gastroenterol; 2022 Aug; 80(2):66-71. PubMed ID: 36004633
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
Rao K; Higgins PD
Inflamm Bowel Dis; 2016 Jul; 22(7):1744-54. PubMed ID: 27120571
[TBL] [Abstract][Full Text] [Related]
19. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
Solanky D; Pardi DS; Loftus EV; Khanna S
Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
[TBL] [Abstract][Full Text] [Related]
20.
Asempa TE; Nicolau DP
Clin Interv Aging; 2017; 12():1799-1809. PubMed ID: 29123385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
